GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adlai Nortye Ltd (NAS:ANL) » Definitions » Market Cap

Adlai Nortye (Adlai Nortye) Market Cap : $233.21 Mil (As of Jun. 05, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Adlai Nortye Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Adlai Nortye's share price for the quarter that ended in Jun. 2023 was $0. Adlai Nortye's Shares Outstanding (EOP) for the quarter that ended in Jun. 2023 was 36.90 Mil. Therefore, Adlai Nortye's market cap for the quarter that ended in Jun. 2023 was $0.00 Mil.

Adlai Nortye's annual market cap stayed the same from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($0.00 Mil) but then increased from Dec. 2022 ($0.00 Mil) to Dec. 2023 ($331.73 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Adlai Nortye's Enterprise Value for Today is $159.62 Mil.

Adlai Nortye Market Cap Historical Data

The historical data trend for Adlai Nortye's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adlai Nortye Market Cap Chart

Adlai Nortye Annual Data
Trend Dec21 Dec22 Dec23
Market Cap
- - 331.73

Adlai Nortye Quarterly Data
Dec21 Mar22 Jun22 Dec22 Mar23 Jun23 Dec23
Market Cap Get a 7-Day Free Trial - - - - 331.73

Competitive Comparison of Adlai Nortye's Market Cap

For the Biotechnology subindustry, Adlai Nortye's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Adlai Nortye's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Adlai Nortye's Market Cap distribution charts can be found below:

* The bar in red indicates where Adlai Nortye's Market Cap falls into.


Adlai Nortye Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Adlai Nortye's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=$8.99*36.9003
=$331.73

Adlai Nortye's Market Cap for the quarter that ended in Jun. 2023 is calculated as

Market Cap (Q: Jun. 2023 )=Share Price (Q: Jun. 2023 )*Shares Outstanding (EOP) (Q: Jun. 2023 )
=$0*36.9003
=$0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Adlai Nortye  (NAS:ANL) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Adlai Nortye Market Cap Related Terms

Thank you for viewing the detailed overview of Adlai Nortye's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Adlai Nortye (Adlai Nortye) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adlai Nortye Ltd (NAS:ANL) » Definitions » Market Cap
Comparable Companies
MGTX KALV JANX AVTE ABUS VYGR BLUE AGEN FUSN CRBU OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N2U0:Germany
Address
685 US Highway 1, North Brunswick, NJ, USA, 08902
Website
https://www.adlainortye.com
Adlai Nortye Ltd is a global clinical-stage biotechnology company focused on the discovery and development of innovative cancer therapies for patients across the spectrum of tumor types. The company has robust pipeline of drug candidates it includes buparlisib (AN2025), palupiprant (AN0025), and AN4005, as well as four preclinical candidates.

Adlai Nortye (Adlai Nortye) Headlines

From GuruFocus

Adlai Nortye Ltd. Announces Pricing of Initial Public Offering

By Marketwired • 09-29-2023

Adlai Nortye Ltd. & Nucleai awarded ESMO 2023 BEST Poster Award

By Marketwired • 10-23-2023

Adlai Nortye Ltd. Announces Closing of Initial Public Offering

By Marketwired • 10-03-2023